Compare VRCA & ALIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VRCA | ALIS |
|---|---|---|
| Founded | 2013 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5M | 83.9M |
| IPO Year | 2018 | N/A |
| Metric | VRCA | ALIS |
|---|---|---|
| Price | $5.60 | $10.00 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 91.9K | 1.9K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $35,577,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $92.12 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 370.22 | N/A |
| 52 Week Low | $0.39 | $9.87 |
| 52 Week High | $9.82 | $10.07 |
| Indicator | VRCA | ALIS |
|---|---|---|
| Relative Strength Index (RSI) | 51.38 | 51.84 |
| Support Level | $5.18 | $9.98 |
| Resistance Level | $6.48 | $10.02 |
| Average True Range (ATR) | 0.48 | 0.01 |
| MACD | 0.09 | -0.00 |
| Stochastic Oscillator | 73.23 | 57.14 |
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Calisa Acquisition Corp is a blank check company with the purpose of effecting a merger, asset acquisition, stock exchange, stock purchase, reorganization, or similar business combination.